Lanadelumab 300 mg

Lanadelumab in Long-term Prophylaxis of Acquired Angioedema

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults